Stay updated on Abbott Press Releases

Sign up to get notified when there's something new on the Abbott Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Abbott Press Releases page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added two new press releases on Mar 11, 2026: Abbott and Real Madrid launch a nationwide effort to build the next Abbott Dream Team, and a study showing rising diabetic ketoacidosis and gaps in ketone monitoring. Removed two older 2025 releases: Navitor TAVI CE Mark expansion and the Abbott quarterly dividend.
    Difference
    2%
    Check dated 2026-03-12T02:21:52.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Added the Feb 27, 2026 press release announcing FDA approval for the CardioMEMS remote heart failure monitoring reader. Removed the Aug 25, 2025 press release about the CE mark for the dissolving stent.
    Difference
    0.8%
    Check dated 2026-03-04T23:51:05.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Added a new press release announcing Abbott's 409th consecutive quarterly dividend (Feb 20, 2026) and removed an older blood-donation campaign release (Aug 18, 2025).
    Difference
    0.8%
    Check dated 2026-02-25T19:48:46.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Added two new press release entries for Feb 6, 2026 related to Abbott ablation catheters and stroke risk reduction, and removed two older Q2 2025 press releases from the listing.
    Difference
    2%
    Check dated 2026-02-11T11:26:55.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Two new press releases were added (Q4 2025 results with 2026 outlook; five-year neuromodulation data) and two older releases were removed (dividend announcement; 'Food is Medicine' diabetes research).
    Difference
    2%
    Check dated 2026-01-28T06:23:08.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added Jan 20, 2026 press release: Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms. Removed May 27, 2025 press release: Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery.
    Difference
    0.8%
    Check dated 2026-01-21T04:09:32.000Z thumbnail image

Stay in the know with updates to Abbott Press Releases

Enter your email address, and we'll notify you when there's something new on the Abbott Press Releases page.